Phase III trial of tiotropium as add-on therapy to low-dose inhaled corticosteroids for patients with symptomatic mild persistent asthma: Design and planned analyses

被引：0

作者：

Paggiaro, P. ^{[1
]}

Engel, M. ^{[2
]}

Tudoric, N. ^{[3
]}

Forstner, B. ^{[4
]}

Radeczky, E. ^{[5
]}

Zubek, V. ^{[6
]}

Blahova, Z. ^{[7
]}

Moroni-Zentgraf, P. ^{[2
]}

机构：

[1] Univ Pisa, Dipartimento Cardiotorac Resp Pathophysiol, Pisa, Italy

[2] Boehringer Ingelheim Pharma GmbH & Co KG, TA Resp Dis, Ingelheim, Germany

[3] Univ Hosp Dubrava, Zagreb, Croatia

[4] Pneumol Pract Forstner MD, Wels, Austria

[5] Men Care Szazhalom Hlth Ctr, Szazhalombatta, Hungary

[6] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA

[7] Boehringer Ingelheim RCV GmbH & Co KG, Clin Dev, Vienna, Austria

来源：

关键词：

Asthma; -; management; Bronchodilators; Lung function testing;

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

3244

引用

页数：1